The Mooc (Massive Open Online Course) “At the heart of medical radioactivity” of the University of Nantes presents in different stages the interest of medical radioactivity, from the design of a radiopharmaceutical drug to its use in the patient.
In partnership with :
This Mooc, coordinated by Caroline Bodet-Milin and Mickaël Bourgeois and piloted by Marie-Hélène Gaugler and the Service de Production et d’Innovation Numérique (S.P.I.N.) of the University of Nantes, was opened in 2019. It includes 24 episodes, divided into six sections :
Introduction
- History of nuclear medicine (video now unavailable)
- Medical uses of ionizing radiation
What is radioactivity ?
- Journey to the heart of matter (video now unavailable)
- The origins of radioactivity
- The different types of radioactivity
- Concepts in radiobiology
Production of radioactive isotopes
- Cyclotron production: the example of Fluorine-18
- Cyclotron production: the example of Astatine-211
- The neutron reactor: example of Iodine-131 production (video now unavailable)
- Generator production: example of metastable Technetium-99
Radiopharmaceuticals : definition and mode of action
- What is a radiopharmaceutical?
- How radiopharmaceuticals work : the concept of molecular targeting
- Radiopharmaceuticals for diagnostic applications
- Radiopharmaceuticals for therapeutic applications
Medical applications
- Patient pathway – Diagnostic tests in conventional nuclear medicine: an example of bone and myocardial scintigraphy
- Patient pathway – Diagnostic tests using positron emission tomography : example of FDG PET
- Patient pathway – Therapeutic applications : an example of Iodine-131 radiotherapy
- Contribution of nuclear medicine to personalized medicine
- Contribution of nuclear medicine in the management of breast cancer
- Use of ionizing radiation in external radiotherapy
Radioprotection
- Radiation protection : regulatory framework and theoretical data
- Practical radiation protection
- Perception of radioactivity, theoretical data
- The hospitalization experience in a shielded room of patients with thyroid cancer treated with iodine-131